Abstract: Searching for new types of biological activities among preliminarily identified hit compounds is a key challenge in modern medicinal chemistry. In our study, a previously studied 3-[5-(1H-indol-3-ylmethylene)-4-oxo-2-thioxothiazolidin-3-yl]-propionic acid (Les-6614) was screened for antimicrobial, antifungal, anti-allergic and antitumor activities. Moreover, cytotoxicity, molecular docking, and, the SwissAdme online target screening were accomplished. It was determined that the Les-6614 has slight antimicrobial and antitumor activity. However, the studied compound decreased IgE levels in sensitized guinea pigs by 33-86% and reduced IgA, IgM, IL-2, and TNF-α, indicating anti-inflammatory and anti-allergic activities. According to the SwissADME web tool, target predictions Les-6614 potentially has an affinity for Lysosomal protective protein, Thromboxane-A synthase, and PPARγ. The molecular docking confirmed that the studied 2-thioxo-4-thiazolidinone derivative showed good bonding with LLP and TXAS leading to stable protein-ligand complexes. Also, the Les-6614 is a potential PPARγ modulator, which is important in the pathogenesis of allergy, cancer, and cardiovascular diseases.

The review presents literature data on the effect of nonsteroidal anti-inflammatory drugs  (NSAIDs) on the formation of bacterial biofilms. The role of biofilm structures as a factor of  virulence of microorganisms is shown, and the protective reactions of a macroorganism in  infectious processes caused by bacteria — producers of biofilms are characterized. The article  also provides the examples of methods for studying biofilm formation and strategies for managing this process. The prospects of further study of the complex interaction between bacterial pathogens in biofilms are shown, which may help to develop further therapeutic strategies  against the biofilm-dependent infections.
K e y w o r d s: NSAIDs, microbiota, dysbiosis, prostanoids, cyclooxygenase, biofilms

616-314.17-008.1-085.27

Epidemiology and Etiopathogenetic Factors of the Development of Aggressive Forms of Periodontitis

The purpose of the work was to study the etiology and main etiopathological factors of the development of aggressive forms of periodontitis based on the analysis of additional pathogenetic aspects of mineral metabolism disorders according to modern literature. Materials and methods. The bibliosemantic method was used to clarify the state of the problem, study the analysis of the results of previous scientific research based on literature sources and electronic resources. Results. Periodontitis is the most widespread disease among all periodontal pathologies (chronic generalized periodontitis occurs in 90% of cases). Until recently, aggressive forms of periodontitis were not given due attention, since according to epidemiological studies by S. Renvert and M. Wikstom (1996), in the general structure of periodontal diseases, aggressive forms of periodontitis occur with a frequency of 5–10%. To understand the mechanisms of the development of aggressive forms of periodontitis, attention is paid to their development in children and adolescents. Clinical and radiological examinations of children and adolescents showed different frequency of aggressive forms of periodontitis (localized juvenile periodontitis and generalized juvenile periodontitis): in the USA – 2.27%, in Denmark – 0.1%, in Finland – 0.1%, in Nigeria – 0.8%, in Brazil – 0.3%, in England – 0.17%, in Chile – 0.32%. Studies have shown that aggressive forms of periodontitis are equally common in children and adolescents, regardless of gender. At the same time, localized juvenile periodontitis is 3 times more common in boys, not the same for girls. A new and rather promising vector of periodontology is the study of the role of juvenile changes in the bone skeleton on the development and course of periodontal diseases. The development of mineral metabolism disorders in aggressive forms of periodontitis in different age groups requires further study, while the data obtained by molecular geneticists become relevant for understanding the possible ways of research. Considering the fact that the jaw bones are a component of the skeleton, the strength of which can be affected by various exogenous and endogenous factors, in particular genetic ones, the main direction of searching for candidate sensitivity genes is conducted among the markers of bone metabolism disorders. Of many candidate genes that determine bone mineral density, the most well-known is the vitamin D receptor gene. Conclusion. The analysis of the available literature showed that the study of the role of mineral and bone metabolism disorders in the emergence and development of aggressive forms of periodontitis has a wide scientific perspective, and obtaining new data on the state of systemic regulatory factors and their effects on the local mechanisms of periodontal tissue damage will allow not only to improve the diagnosis of various forms, but also to increase the effectiveness of the treatment of this pathology

Abstract
 At present, not a single case of endometriosis of the temporal bone has been described in
medical science, as well as the association of endometriosis with dysfunction of the
temporomandibular joint and the development of degenerative joint disease, as well as the
treatment of these diseases with gestagens.
 This study presents a patient with primary complaints of constant acute pain in the left TMJ
(temporomandibular joint) aggravated by any movements of the lower jaw, inability to open the
mouth wide, and persistent headaches. The first-listed diagnosis was TMJ dysfunction and
degenerative joint disease, and the final diagnosis was temporal bone endometriosis and
secondary joint dysfunction. An articular splint helped alleviate initial symptoms, and the final relief
came after placing on progestogen therapy. Joint dysfunction has a polyetiological nature and
requires an integrated approach in diagnosis and treatment to achieve a clinical result.
 Case Report (J Int Dent Med Res 2022; 15(3): 1305-1310)
 Keywords: Invasive endometriosis, endometrial implants, TMJ, TMD.
 Received date: 17 May 2022 Accept date: 03 July 2022 

UDC616.31:615.015+664.34

Iu. Z. Labush